Suppr超能文献

经心内膜 CD34 细胞移植治疗非致密化心肌病:首例人体病例研究。

Transendocardial CD34 Cell Transplantation in Noncompaction Cardiomyopathy: First-in-Man Case Study.

机构信息

1 Advanced Heart Failure and Transplantation Center, Department of Cardiology, UMC Ljubljana, Ljubljana, Slovenia.

2 Department of Hematology, UMC Ljubljana, Ljubljana, Slovenia.

出版信息

Cell Transplant. 2018 Jul;27(7):1027-1030. doi: 10.1177/0963689718779349. Epub 2018 Jul 5.

Abstract

Noncompaction cardiomyopathy is a rare congenital heart disorder characterized by an arrest of the myocardial compaction process. This results in the altered formation of coronary microvessels with a resulting decrease in myocardial perfusion. Transendocardial CD34 cell transplantation has been shown to increase myocardial perfusion and function in patients with non-ischemic heart failure. In our first-in-man case study, we investigated the feasibility, safety and clinical effect of transendocardial CD34 cell therapy in a patient with noncompaction cardiomyopathy.

摘要

非致密性心肌病是一种罕见的先天性心脏疾病,其特征是心肌致密化过程停止。这导致冠状动脉微血管形成异常,心肌灌注减少。经心内膜 CD34 细胞移植已被证明可增加非缺血性心力衰竭患者的心肌灌注和功能。在我们的首例人体病例研究中,我们研究了经心内膜 CD34 细胞治疗在非致密性心肌病患者中的可行性、安全性和临床效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcf5/6158552/4a6fb00a99b5/10.1177_0963689718779349-fig1.jpg

相似文献

10
Noncompaction Cardiomyopathy and Stroke: Case Report and Literature Review.非致密型心肌病与中风:病例报告及文献综述
J Stroke Cerebrovasc Dis. 2015 Aug;24(8):e213-7. doi: 10.1016/j.jstrokecerebrovasdis.2015.04.014. Epub 2015 Jun 3.

本文引用的文献

3
Left ventricular non-compaction cardiomyopathy.左心室心肌致密化不全心肌病。
Lancet. 2015 Aug 22;386(9995):813-25. doi: 10.1016/S0140-6736(14)61282-4. Epub 2015 Apr 9.
7
Noncompaction cardiomyopathy: a current view.非致密性心肌病:现状观点。
Arq Bras Cardiol. 2011 Jul;97(1):e13-9. doi: 10.1590/s0066-782x2011000900021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验